| Catalog Number |
09D89-21 |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
Misdiagnosis (2159)
|
| Date of Event |
06/26/2016
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Abbott laboratories identified negative interference from the drug n-acetyl cysteine (nac) with the architect lactic acid assay leading to falsely depressed lactic acid results.A product correction letter was issued to all current architect lactic acid customers.The letter informs the customer that patients undergoing treatment with n-acetyl cysteine (nac) may have falsely depressed lactic acid results.Architect lactic acid list number 09d89 is being discontinued.Customers who receive the final lots of list number 09d89 will be notified of the interference from nac via additional labeling (kit stuffer) contained within the reagent kit.
|
| |
|
Event or Problem Description
|
|
The customer stated that they were made aware of an alert regarding several siemens assays and interference in patients treated with nac.The customer inquired as to whether abbott laboratories has any concerns regarding similar interference with architect assays including lactic acid.No discrepant architect patient results or impact to patient management was reported.
|
| |
|
Search Alerts/Recalls
|